ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Cefotaxime Sodium Powder, for Solution shortage

Current  6 presentations · 2 manufacturers · first FDA posting 2015-02-17 · last update 2026-10-14

Manufacturers: Hikma Pharmaceuticals USA, Inc., SteriMax, Inc.

Stated reasons (per FDA): Demand increase for the drug

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10)Hikma Pharmaceuticals USA, Inc.Current
Unavailable
 Demand increase for the drugEstimated recovery: TBDPosted 02/17/2015
Updated 10/14/2026
Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 0143-9931-25)Hikma Pharmaceuticals USA, Inc.Current
Unavailable
 Demand increase for the drugEstimated recovery: TBDPosted 02/17/2015
Updated 10/14/2026
Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 0143-9933-25)Hikma Pharmaceuticals USA, Inc.Current
Unavailable
 Demand increase for the drugEstimated recovery: TBDPosted 02/17/2015
Updated 10/14/2026
Cefotaxime Sodium, Powder, for Solution, 10 g (NDC 0143-9935-01)Hikma Pharmaceuticals USA, Inc.Current
Unavailable
 Demand increase for the drugEstimated recovery: TBDPosted 02/17/2015
Updated 10/14/2026
Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 21586-011-02)SteriMax, Inc.Current
Available
 —Posted 02/17/2015
Updated 06/15/2026
Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 21586-012-02)SteriMax, Inc.Current
Available
 —Posted 02/17/2015
Updated 06/15/2026

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)